|
Volumn 4, Issue 6, 2014, Pages 624-625
|
Palbociclib ups PFS in HER2-/ER+ breast cancer
[No Author Info available]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
6-ACETYL-8-CYCLOPENTYL-5-METHYL-2-(5-PIPERAZIN-1-YLPYRIDIN-2-YLAMINO)-8H-PYRIDO(2,3-D)PYRIMIDIN-7-ONE;
ANTINEOPLASTIC AGENT;
AROMATASE INHIBITOR;
CDK4 PROTEIN, HUMAN;
CDK6 PROTEIN, HUMAN;
CYCLIN DEPENDENT KINASE 4;
CYCLIN DEPENDENT KINASE 6;
EPIDERMAL GROWTH FACTOR RECEPTOR 2;
ESTROGEN RECEPTOR;
LETROZOLE;
NITRILE;
PIPERAZINE DERIVATIVE;
PROTEIN KINASE INHIBITOR;
PYRIDINE DERIVATIVE;
TRIAZOLE DERIVATIVE;
ANTAGONISTS AND INHIBITORS;
BREAST NEOPLASMS;
DISEASE FREE SURVIVAL;
FEMALE;
HUMAN;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
AROMATASE INHIBITORS;
BREAST NEOPLASMS;
CYCLIN-DEPENDENT KINASE 4;
CYCLIN-DEPENDENT KINASE 6;
DISEASE-FREE SURVIVAL;
FEMALE;
HUMANS;
NITRILES;
PIPERAZINES;
PROTEIN KINASE INHIBITORS;
PYRIDINES;
RECEPTOR, ERBB-2;
RECEPTORS, ESTROGEN;
TRIAZOLES;
|
EID: 84906903182
PISSN: None
EISSN: 21598290
Source Type: Journal
DOI: 10.1158/2159-8290.CD-NB2014-053 Document Type: Note |
Times cited : (7)
|
References (0)
|